CC-101 - Clarion Cells
tacrolimus oral - Generic mfg.
suNR1se II: CC-101 (f/k/a NR1) Neural Stem Cell Transplantation for Adults With Chronic Ischemic Stroke (clinicaltrials.gov) - Jul 18, 2026 - P2 | N=36 | Not yet recruiting | Sponsor: Clarion Cells, Inc. 
New P2 trial • Cardiovascular • Ischemic stroke • Transplantation
http://clinicaltrials.gov/ct2/show/NCT07709845
 
Jul 18, 2026